Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 238

Results For "IND"

6314 News Found

Pfizer launches digital platform ‘PfizerForAll’
Digitisation | August 27, 2024

Pfizer launches digital platform ‘PfizerForAll’

PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care


Merck announces Phase 3 trial initiation for Bomedemstat
Clinical Trials | August 27, 2024

Merck announces Phase 3 trial initiation for Bomedemstat

The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)


Shilpa Medicare announces positive outcome of Phase 3 studies of NorUDCA
Clinical Trials | August 26, 2024

Shilpa Medicare announces positive outcome of Phase 3 studies of NorUDCA

Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India


Akums appoints Amrut Medhekar as CEO - CDMO Business
People | August 26, 2024

Akums appoints Amrut Medhekar as CEO - CDMO Business

e brings over 27+ years of rich pharmaceutical experience


Akums Q1 FY25 revenue up 5.1%
News | August 26, 2024

Akums Q1 FY25 revenue up 5.1%

The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually


Royal Sense launches stergic dengue IgG/IgM rapid test
Healthcare | August 25, 2024

Royal Sense launches stergic dengue IgG/IgM rapid test

The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples


BioIVT acquires ZenBio
News | August 25, 2024

BioIVT acquires ZenBio

ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise


BI Sky Global successfully completes FDA MoCRA registration
Drug Approval | August 25, 2024

BI Sky Global successfully completes FDA MoCRA registration

MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States


Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
News | August 24, 2024

Zydus to acquire 50% stake in Sterling Biotech from Perfect Day

The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets